GT Biopharma, Inc.
For the period ended Jul 24, 2025. Filed Jul 24, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jul 24, 2025 · Filed Jul 24, 2025
Use the contents to explore the available documents and sections.
GTBP$4.42-2.6%Stored close · as of Nov 6, 2026
Contents
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report:
(Date of earliest event reported)
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.